ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
CP086200_1_655 # 678366 # 679466 # 1 # ID=1_655;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.683	CP086200_1_655	678366	679466	+	Strict	175	177.178	vanT gene in vanG cluster	33.63	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGCGTCCTGCGCAAGCGTCGATCGATCTGGAGGCGTTGCGCCACAACTACCGCCTGGCCAAGCGCCTGGGTGGCAGCAAGGCGCTGGCGGTGGTCAAGGCCGATGCTTACGGGCATGGCGCAGTGCCTTGCGCGCAGGCGCTGGAACCGGAGGCCGATGGCTTCGCGGTGGCCTGCATCGAAGAGGCGCTGAAACTGCGCCAGGCCGGCATCCGCGCGCCAATCCTGTTGCTGGAAGGGTTCTTCGAGCACGACGAGCTGCGCCTGATCGCCGAGCACGACCTGTGGACGGTGGCGGCTACGCCGCAACAGGTGCGCGCGCTGGCCGCGTTCCAGAGCCCACGACCGTTGCGGGTGTGGTTGAAGATGGACAGCGGCATGCATCGGCTGGGCCTGTCGCCGGAAGACTTCCGCGCCGCATGGCTGCGCCTGCGCGGGCTGCCGCAGATCGCCTCGCTGGTGCTGATGACCCACCTGGCGCGCGCCGACGAATTGGACTGCAGCCGCACAGACGAACAGGCGGTGGCCTTTGCGCTGACCGCCGGCGGCATGCGCGCGGAAACCAGTCTGCGCAATTCGCCCGGCCTGCTCGGCTGGCCGGCGCTGCGCAACGACTGGTCGCGCCCGGGGCTGATGTTGTACGGCGCCAACCCGTTCCCGCAGGACACCGAGAACACTGCGCAATTGCGCCCGGTGATGACGCTGCGCTCGCGCATCATTTTGGTCCGCGACCTGCCGGTCGGCGAACCGGTGGGCTACGGCGCCCGTTTTGTCGCCGAACGACCGACCCGCGTCGGCGTGGTGGCGATGGGCTATGCCGACGGCTACCCGCAGTTCGCGCCGAACGGCACCCCGGTGCTGGTGGATGGCCAGGTCTGCCCATTGATCGGTCGCGTCTCGATGGACATGCTCACCGTGGACCTCACCGACCATCCGCAGGCCGACATTGGTGCCACCGTGCAGCTGTGGGGCCAGGCACCACGCGTTGGCCCACTGGCCACGCAATGCAATGTCAGCGCGTATCAGCTGTTGTGTGGACTCAAGCGCGTGCCGCGGACGTATGTGGCTAGTGCGGCAGTGGGCGAGGTTGCAGCGCGGTAA	MRPAQASIDLEALRHNYRLAKRLGGSKALAVVKADAYGHGAVPCAQALEPEADGFAVACIEEALKLRQAGIRAPILLLEGFFEHDELRLIAEHDLWTVAATPQQVRALAAFQSPRPLRVWLKMDSGMHRLGLSPEDFRAAWLRLRGLPQIASLVLMTHLARADELDCSRTDEQAVAFALTAGGMRAETSLRNSPGLLGWPALRNDWSRPGLMLYGANPFPQDTENTAQLRPVMTLRSRIILVRDLPVGEPVGYGARFVAERPTRVGVVAMGYADGYPQFAPNGTPVLVDGQVCPLIGRVSMDMLTVDLTDHPQADIGATVQLWGQAPRVGPLATQCNVSAYQLLCGLKRVPRTYVASAAVGEVAAR	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	51.40	gnl|BL_ORD_ID|1522|hsp_num:0	1561			1032	2028	vancomycin
CP086200_1_4068 # 4228255 # 4229052 # -1 # ID=1_4068;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.664	CP086200_1_4068	4228255	4229052	-	Strict	50	63.929	vanY gene in vanM cluster	32.12	3002961	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGCGCAATTGCCCACGTCTGCTCCTCAATACCAGCACGATCGAACTGTGGCCGGCCGATCTGTTGCGCGCGCGCGGCAACGCGGATGCGCGCGTGCTGGCGCAGGCCGATTGGCTATTGCGACGTAAGCGCGATGGGCGCTATCTGGCGGCGCATCTGCCACAAGGCATGATGCCGTTGATCCCGCGGCTGGCACGCGAGCCGGGCCTGGATGACGCGTTGGACCGTCTGCAGACCGCCAGTGGCCGCGCCGGCCAAGTCCTCGACGACGTGCTTGCGATCGACGGATTGCAGCGCCGACTGAGCCAACTGGGACTCGCTGCAAACGGCTATGTTGAGCAGACCGGTCTGCAACTGATCGCCGAACCGGTTGCCCTGCAGTTTGGCGGGCGCGATCGCTTCGGTCGTCCGCTGTGGCTCAGTGCCGGCGCTGCGCGTGCATGGCGACAGCTGCGCGCGGCTGCGCTGCGCGCGGACATCGTGCTCGATGCGATCTCCGGCTACCGCAGCCACGACTACCAACTGGGCATCTTCGAGCGCAAGCGCGCGCGCGGGCTCACCCTTGAGCAGATTCTGGCGGTCAACGCCGCGCCAGGTTTCAGCGAACATCACAGCGGCGACGCCCTGGACATCGGCACACCGGGCGAACCGCCGGCCGAGGAATCCTTCGCAACCACGCCTGCATTCGCCTGGTTGCGCAACAACGCGAACGCGTTCGGCTACCGCCTGAGTTATCCACGCGACAACCCGCATGGCATCGTCTACGAGCCGTGGCACTGGCGTTGGTCGGCAGCGTAA	MRNCPRLLLNTSTIELWPADLLRARGNADARVLAQADWLLRRKRDGRYLAAHLPQGMMPLIPRLAREPGLDDALDRLQTASGRAGQVLDDVLAIDGLQRRLSQLGLAANGYVEQTGLQLIAEPVALQFGGRDRFGRPLWLSAGAARAWRQLRAAALRADIVLDAISGYRSHDYQLGIFERKRARGLTLEQILAVNAAPGFSEHHSGDALDIGTPGEPPAEESFATTPAFAWLRNNANAFGYRLSYPRDNPHGIVYEPWHWRWSAA	MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR	113.73	gnl|BL_ORD_ID|1673|hsp_num:0	1713			108	474	vancomycin; teicoplanin
CP086200_1_4379 # 4566041 # 4566175 # -1 # ID=1_4379;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.519	CP086200_1_4379 	4566041	4566175	-	Strict	700	21.1718	CMY-78	100.0	3002091	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGTTAACAGGCCTTAGTTGTCGCATCCCGGACGATGGCATAGATCCCAAACGCTATCCACTCTTCATGGCCCAAGTCGTCTTGCAGGAGTTGATAGAGTCCCTGCAATGGACTCCGGGAGCCAAGCCATGCTGA	MLTGLSCRIPDDGIDPKRYPLFMAQVVLQELIESLQWTPGAKPC	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPGDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ	11.55	gnl|BL_ORD_ID|1505|hsp_num:0	1634	True	loose hit with at least 95 percent identity pushed strict	480	501	
